Skip to main content
. 2021 Feb 15;26(5):e838–e846. doi: 10.1002/onco.13701

Figure 2.

Figure 2

Progression‐free survival (A) and overall survival (B) by treatment in the second analysis of the national POLA cohort. Abbreviations: OS, overall survival; PCV, procarbazine, lomustine, and vincristine; PFS, progression‐free survival; RT, radiotherapy; TMZ, temozolomide.